Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Celularity Inc. (CELU)

Compare
1.8253
-0.0047
(-0.26%)
As of 11:40:45 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
48,200
22,771
17,975
21,335
14,278
Cost of Revenue
17,255
16,016
19,665
9,653
4,932
Gross Profit
30,945
6,755
-1,690
11,682
9,346
Operating Expense
70,869
83,234
146,577
161,886
87,437
Operating Income
-39,924
-76,479
-148,267
-150,204
-78,091
Net Non Operating Interest Income Expense
-4,746
-2,695
365
-2,839
-1,984
Other Income Expense
9,628
-117,111
162,107
52,945
-132,858
Pretax Income
-35,042
-196,285
14,205
-100,098
-212,933
Tax Provision
10
10
13
20
-4,700
Net Income Common Stockholders
-35,052
-196,295
14,192
-100,118
-208,233
Diluted NI Available to Com Stockholders
-35,052
-196,295
14,192
-100,118
-208,233
Basic EPS
-100.39
-110.20
1.01
-14.90
-17.00
Diluted EPS
-100.39
-110.20
0.95
-14.90
-17.00
Basic Average Shares
5,083.4740
1,781.3040
13,990.7030
6,705.7270
12,248.7170
Diluted Average Shares
5,083.4740
1,781.3040
14,983.0020
6,705.7270
12,248.7170
Total Operating Income as Reported
-15,763
-192,287
-25,600
-109,059
-151,925
Total Expenses
88,124
99,250
166,242
171,539
92,369
Net Income from Continuing & Discontinued Operation
-35,052
-196,295
14,192
-100,118
-208,233
Normalized Income
-49,645.6700
-86,651
-150,584
-154,745
-74,291.9880
Interest Income
369
320
365
332
370
Interest Expense
5,115
3,015
--
3,171
2,354
Net Interest Income
-4,746
-2,695
365
-2,839
-1,984
EBIT
-29,927
-193,270
14,205
-96,927
-210,579
EBITDA
-21,585
-183,946
23,641
-88,110
-202,405
Reconciled Cost of Revenue
10,843
8,885
12,422
3,028
152
Reconciled Depreciation
8,342
9,324
9,436
8,817
8,174
Net Income from Continuing Operation Net Minority Interest
-35,052
-196,295
14,192
-100,118
-208,233
Total Unusual Items Excluding Goodwill
18,473
-109,644
164,776
54,627
-136,954
Total Unusual Items
18,473
-109,644
164,776
54,627
-136,954
Normalized EBITDA
-40,058
-74,302
-141,135
-142,737
-65,451
Tax Rate for Calcs
0.0002
--
--
--
0
Tax Effect of Unusual Items
3,879.3300
--
--
--
-3,012.9880
12/31/2020 - 8/8/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SRNE Sorrento Therapeutics, Inc.
0.0007
0.00%
 
AARD Aardvark Therapeutics, Inc. Common Stock
7.30
-5.69%
 
PRLD Prelude Therapeutics Incorporated
0.8403
+5.08%
 
ZNTL Zentalis Pharmaceuticals, Inc.
1.6093
-11.09%
 
ENTO Entero Therapeutics, Inc.
0.4995
+0.06%
 
LXEO Lexeo Therapeutics, Inc.
3.6800
-10.24%
 
VINC Vincerx Pharma, Inc.
0.5096
-5.47%
 
MOLN Molecular Partners AG
4.3500
+6.10%
 
FBRX Forte Biosciences, Inc.
8.52
+3.84%
 
CYCN Cyclerion Therapeutics, Inc.
2.4500
-3.92%